1002309-48-9 Usage
General Description
1-Cyclobutyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole is a complex organic compound that comprises of a cyclobutyl group, a pyrazole group, and a tetramethyl borate group. This chemical, often used as a reagent or intermediate in organic synthesis, is part of the boronic ester class of compounds. These types of chemicals are commonly used for a variety of applications in pharmaceutical, agricultural, and material science owing to their versatility in various chemical reactions, especially in the Suzuki-Miyaura cross-coupling reaction which is widely used in organic synthesis. Its properties include stability under standard temperature and pressure, however, detailed information about its physical and chemical properties, reactivity, safety measures, or potential uses in specific products or processes may not be widely available in public databases due to its specificity as a reagent or intermediate.
Check Digit Verification of cas no
The CAS Registry Mumber 1002309-48-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,2,3,0 and 9 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1002309-48:
(9*1)+(8*0)+(7*0)+(6*2)+(5*3)+(4*0)+(3*9)+(2*4)+(1*8)=79
79 % 10 = 9
So 1002309-48-9 is a valid CAS Registry Number.
1002309-48-9Relevant articles and documents
CARBOXYLIC ACID AROMATIC AMIDES AS ANTAGONISTS OF BRADYKININ B1 RECEPTOR
-
Page/Page column 152-153, (2018/07/29)
The present invention relates to carboxylic acid aromatic amides compounds of general formula (I) as described and defined herein, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing
FUSED HETEROCYCLIC DERIVATIVES AND METHODS OF USE
-
Page/Page column 113, (2010/11/29)
Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.